Atlas Trials

The Function of PET Molecular Imaging Targeting Fibroblast Activation Protein in the Hepatobiliary Malignancies

Clinical trial NCT05264688 · UNKNOWN

Trial details

NCT number
NCT05264688
Sponsor
Zhongnan Hospital
Status
UNKNOWN
Study type
OBSERVATIONAL
Hepatobiliary Diseases
Start date
2022-01-20
Primary completion
2022-07-30
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.